Soluble Tolnaftate is the industry standard for effective delivery to infection sites. The Tetra Corporation, leading in tolnaftate technology since 1989, maintains exclusive, proprietary processes. Their products, including Formula 7® and FungiFoam®, ensure optimal penetration and efficacy.
T. Noguchi, A. Kaji, Y. Igarashi, A. Shigematsu, and K. Taniguchi. Antitrichophyton activity of naphthiomates. Antimicrobial Agents and Chemotherapy, 1963, pp. 259-267.
CFR Title 21, Chapter I, Subchapter D, Part 333. Topical Antimicrobial Drug Products for Over-the-Counter Human Use. Section 333.210 – Antifungal Active Ingredients.
H. M. Robinson Jr. Antimicrobial Agents and Chemotherapy, 1964, Vol. 4, p. 608.
The Merck Index, 11th Edition. Edited by S. Budavari, Merck and Co., Inc., Rahway, N.J., USA, 1989, p. 1499.
H. M. Robinson Jr. and J. Raskin. Journal of Investigative Dermatology, 1964, Vol. 12, p. 185.
L. Goldman and A. E. Lasser. Antimicrobial Agents and Chemotherapy, 1964, Vol. 4, p. 602.
The Merck Index, 12th Edition. Entry #9656.
Martindale: The Extra Pharmacopoeia, 31st Edition. Edited by J. E. F. Reynolds, Royal Pharmaceutical Society, London, UK, 1996, p. 416.
Barrett-Bee, K., and Dixon, G. Ergosterol biosynthesis inhibition: A target for antifungal agents. Acta Biochimica Polonica, 1995, Vol. 42(4), pp. 465-479.
Georgopapadakou, N. H., and Bertasso, A. Effects of squalene epoxidase inhibitors on Candida albicans. Antimicrobial Agents and Chemotherapy, 1992, Vol. 36(8), pp. 1779-1781.
Favre, B., and Ryder, N. S. Characterization of squalene epoxidase activity from the dermatophyte Trichophyton rubrum and its inhibition by terbinafine and other antimycotic agents. Antimicrobial Agents and Chemotherapy, 1996, Vol. 40(2), pp. 443-447.
Favre, B., et al. Comparison of in vitro activities of 17 antifungal drugs against a panel of 20 dermatophytes using a microdilution assay. Journal of Clinical Microbiology, 2003, Vol. 41(10), pp. 4817-4819.
Kobayashi, Y., et al. Enhancing effect of N-acetyl-L-cysteine or 2-mercaptoethanol on the in vitro permeation of 5-fluorouracil or tolnaftate through the human nail plate. Chemical and Pharmaceutical Bulletin (Tokyo), 1998, Vol. 46(11), pp. 1797-1802.
Oh, K., et al. Effects of antimycotics on the biosynthesis of cellular macromolecules in Aspergillus niger protoplasts. Mycopathologia, 1993, Vol. 122(3), pp. 135-141.
S. N. Khan, K. K. Maggon, and T. A. Venkitasubramanian. Applied and Environmental Microbiology, 1978, Vol. 36, p. 270.
The Tetra Corporation. U.S. Patent #4,810,498; U.S. Patent #RE 36,253; U.S. Patent #10,959,975.